Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 4, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K

Modelling lymphoma therapy and outcome.

Katja Roesch1, Dirk Hasenclever, Markus Scholz

  • 1Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16-18, 04107, Leipzig, Germany, katja.roesch@imise.uni-leipzig.de.

Bulletin of Mathematical Biology
|December 17, 2013
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Blood advances·2026
Same author

Cardiac Biomarkers to Refine Pretest Probability for Coronary Obstruction and Predict Survival After Revascularization in Chronic Coronary Syndrome.

Journal of the American Heart Association·2026
Same author

<i>Trans</i>-eQTLs reveal the architecture of human gene regulatory networks.

medRxiv : the preprint server for health sciences·2026
Same author

Glomerular Filtration Rate, Albuminuria, and Reported Kidney Disease in Comparison: Results From the German National Cohort (NAKO).

Deutsches Arzteblatt international·2026
Same author

Concurrent associations between objective markers and subjective markers of aging with indicators of successful aging: An integrative approach.

European journal of ageing·2026
Same author

Femtosecond concerted rotation of molecules on a 2D material interface.

Nature communications·2026
Same journal

Mathematical Modeling Shows that Overall Infection Burden is Reduced More by Vaccines that Decrease Spread or Accelerate Recovery than those that Lower Severe Infections or Death.

Bulletin of mathematical biology·2026
Same journal

Effects of Seasonal Births and Predation on Disease Spread.

Bulletin of mathematical biology·2026
Same journal

Identifiability, Sensitivity, and Genetic Algorithms in Bacterial Biofilm Selection Models.

Bulletin of mathematical biology·2026
Same journal

Slow Evolution Towards Generalism in a Model of Variable Dietary Range.

Bulletin of mathematical biology·2026
Same journal

CBINN: Cancer Biology-Informed Neural Network for Unknown Parameter Estimation and Missing Physics Identification.

Bulletin of mathematical biology·2026
Same journal

A Cost-Sensitive Behavioral Modeling Analysis of the Early Identification and Control of Infectious Diseases.

Bulletin of mathematical biology·2026
See all related articles

Intensified chemotherapy for lymphoma can paradoxically impair tumor control by depleting immune cells. A mathematical model reveals the immune system

Area of Science:

  • Mathematical Biology
  • Immunology
  • Oncology

Background:

  • Chemotherapy dose and time intensification historically improved lymphoma outcomes.
  • Recent findings indicate overly intense therapies can lead to inferior tumor control.
  • This suggests a critical role for the immune system in managing residual cancer cells post-treatment.

Purpose of the Study:

  • To hypothesize and model the role of the immune system in lymphoma therapy outcomes.
  • To explain the paradoxical effect of intensified chemotherapy leading to poorer tumor control.
  • To investigate how immune cell depletion by intense therapy may facilitate tumor regrowth.

Main Methods:

  • Development of a differential equations model simulating tumor and immune cell dynamics under chemotherapy.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

825
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

16.3K

Related Experiment Videos

Last Updated: May 4, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

825
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

16.3K
  • Incorporation of key features: exponential tumor growth, tumor-induced effector cell production (immunogenicity), and mutual cell destruction.
  • Estimation of patient-specific parameters (growth rate, chemosensitivity, immunogenicity, tumor size) using maximum-entropy distributions based on clinical survival data.

    • Main Results:

    • The model successfully explains the outcomes of five different chemotherapeutic regimens and their associated hazard ratios.
    • It accounts for the observed paradox where intensified chemotherapy can result in inferior tumor control.
    • Patient-specific parameter distributions explain the heterogeneity in therapy outcomes.

    Conclusions:

    • The immune system plays a crucial role in controlling residual lymphoma cells after chemotherapy.
    • Intensified chemotherapy can be detrimental by excessively depleting immune cells, enabling tumor regrowth.
    • The developed mathematical model provides a framework for understanding these effects and predicting outcomes for novel therapeutic strategies.